Evidence map›Paper›PMID 37783716›Full record

ArticleScientific reports2023

Use of medicinal plants during COVID-19 pandemic in Brazil.

Alciellen Mendes da Silva, Ana Luísa Horsth, Élida da Silva Timóteo, Ronaldo José Faria, Patrícia Silva Bazoni, Eduardo Frizzera Meira, Jéssica Barreto Ribeiro Dos Santos, Michael Ruberson Ribeiro da Silva

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation.International journal of molecular sciences · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alciellen Mendes da SilvaHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Ana Luísa HorsthHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Élida da Silva TimóteoHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Ronaldo José FariaHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Patrícia Silva BazoniHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Eduardo Frizzera MeiraHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Jéssica Barreto Ribeiro Dos SantosHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil.
Michael Ruberson Ribeiro da SilvaHealth Evaluation, Technology, and Economics Group, Federal University of Espírito Santo, Alegre, 29500-000, Brazil. mike.ufes@gmail.com.
Universidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal plants are an integrative and complementary health practice widely used by the population. However, its use is not without risks. This study assessed the profile and associated factors with the traditional use of medicinal plants. To this end, a cross-sectional survey study was conducted in a southeastern Brazilian city. Descriptive analysis was performed by frequency distribution and median and interquartile range. Associated factors with the use of medicinal plants were analyzed using Poisson regression with robust variance. A total of 641 people were interviewed, of whom 258 (40.2%) reported using medicinal plants. A total of 79 distinct plants were identified, of whom Melissa officinalis (31.0%), Peumus boldus (24.4%), Mentha spicata (20.9%), Matricaria recutita L. (18.2%), Rosmarinus officinalis (17.0%), and Foeniculum vulgare (14.7%) were the most used. There were no reports of medicinal plants used to treat COVID-19. However, anxiety was the most frequently cited indication for using medicinal plants, a health condition exacerbated by the COVID-19 pandemic. Furthermore, the use of medicinal plants for treating respiratory and gastrointestinal symptoms similar to those in COVID-19 has been identified. There was an association between the use of medicinal plants and females, non-white, lower schooling, higher income, and comorbidities.

Indexed as

COVID-19Plants, MedicinalBrazilCross-Sectional StudiesFemaleHumansPandemicsPhytotherapySurveys and Questionnaires

Identifiers

PMID37783716
PMCPMC10545667
OpenAlexW4387245544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.